Years of dermatology experience and geographic region are associated with outlier performance of excision or destruction for nonmelanoma skin cancer

References

• Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151(10):1–6.
   Web of Science ®Google Scholar
• Skin cancer. 2022. https://www.aad.org/media/stats-skin-cancer
   Google Scholar
• Fahradyan A, Howell AC, Wolfswinkel EM, et al. Updates on the management of Non-Melanoma skin cancer (NMSC). Healthc Basel Switz. 2017;5(4):E82.
   PubMedGoogle Scholar
• Kauvar ANB, Cronin TJ, Roenigk R, et al. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41(5):550–571.
   PubMed Web of Science ®Google Scholar
• Kauvar ANB, Arpey CJ, Hruza G, et al. Consensus for nonmelanoma skin cancer treatment, part II: squamous cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41(11):1214–1240.
   PubMed Web of Science ®Google Scholar
• Chren MM, Linos E, Torres JS, et al. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2013;133(5):1188–1196.
   PubMed Web of Science ®Google Scholar
• Rowe DE, Carroll RJ, Day CL.Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–328.
   PubMedGoogle Scholar
• Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–990.
   PubMed Web of Science ®Google Scholar
• Backman E J, Polesie S, Berglund S, et al. Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial. J Eur Acad Dermatol Venereol. 2022;36(10):1758–1765.
   PubMed Web of Science ®Google Scholar
• Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol. 1991;17(9):720–726.
   PubMedGoogle Scholar
• Nordin P, Stenquist B. Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers. J Laryngol Otol. 2002;116(11):893–898.
   PubMed Web of Science ®Google Scholar
• Nordin P, Larkö O, Stenquist B. Five–year results of curettage–cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by mohs’ surgery. Br J Dermatol. 1997;136(2):180–183.
   PubMed Web of Science ®Google Scholar
• Lindemalm-Lundstam B, Dalenbäck J. Prospective follow-up after curettage-cryosurgery for scalp and face skin cancers. Br J Dermatol. 2009;161(3):568–576.
   PubMed Web of Science ®Google Scholar
• Peikert JM. Prospective trial of curettage and cryosurgery in the management of non-facial, superficial, and minimally invasive basal and squamous cell carcinoma. Int J Dermatol. 2011;50(9):1135–1138.
   PubMed Web of Science ®Google Scholar
• Wilson LS, Pregenzer M, Basu R, et al. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg. 2012;38(4):570–584.
   PubMed Web of Science ®Google Scholar
• Rogers HW, Coldiron BM. A relative value unit–based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009;61(1):96–103.
   PubMed Web of Science ®Google Scholar
• Asgari MM, Bertenthal D, Sen S, et al. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg. 2009;35(7):1041–1049.
   PubMed Web of Science ®Google Scholar
• Guy GP, Machlin SR, Ekwueme DU, et al. Prevalence and costs of skin cancer treatment in the US, 2002 − 2006 and 2007 − 2011. Am J Prev Med. 2015;48(2):183–187.
   PubMed Web of Science ®Google Scholar
• Arits A, Schlangen M, Nelemans P, et al. Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol. 2011;25(5):565–569.
   PubMed Web of Science ®Google Scholar
• Chirikov VV, Stuart B, Zuckerman IH, et al. Physician specialty cost differences of treating nonmelanoma skin cancer. Ann Plast Surg. 2015;74(1):93–99.
   PubMed Web of Science ®Google Scholar
• Skaggs R, Coldiron B. Skin biopsy and skin cancer treatment use in the medicare population, 1993 to 2016. J Am Acad Dermatol. 2021;84(1):53–59.
   PubMed Web of Science ®Google Scholar
• Manternach T, Housman TS, Williford PM, et al. Surgical treatment of nonmelanoma skin cancer in the medicare population. Dermatol Surg. 2003;29(12):1167–1169; discussion 1169.
   PubMed Web of Science ®Google Scholar
• Chren MM, Sahay AP, Sands LP, et al. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Med Care. 2004;42(10):1019–1026.
   PubMed Web of Science ®Google Scholar
• Medicare physician & other practitioners - centers for medicare & medicaid services data. 2022. https://data.cms.gov/provider-summary-by-type-of-service/medicare-physician-other-practitioners
   Google Scholar
• Aggarwal P, Neltner SA, Fleischer ABJ. Risk factors that are associated with outliers in mohs micrographic surgery in the national medicare population, 2018. Dermatol Surg. 2022;48(2):181–186.
   PubMed Web of Science ®Google Scholar
• Krishnan A, Xu T, Hutfless S, et al. Outlier practice patterns in mohs micrographic surgery: defining the problem and a proposed solution. JAMA Dermatol. 2017;153(6):565–570.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lipner SR. Analysis of outlier nail biopsy practice patterns in the medicare provider utilization and payment database 2012–2017. J Am Acad Dermatol. 2021;85(4):986–989.
   PubMed Web of Science ®Google Scholar
• Peck GM, Wang Y, Fleischer AB, et al. Practice region and density, male sex, and specialty predict frequent performers of nail biopsies. J Am Acad Dermatol. 2022;88:688–690.
   PubMed Web of Science ®Google Scholar
• Census Regions and Divisions of the United States [Internet]. US Census Bureau; 2022 [cited 2022 Sep 4]. Available from: https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf
   Google Scholar
• NPPES NPI Files [Internet]. Centers for Medicare and Medicaid Services; 2022 [cited 2022 Sep 4]. Available from: https://download.cms.gov/nppes/NPI_Files.html
   Google Scholar
• Rural-Urban Commuting Area Codes [Internet]. U.S. Department of Agriculture Economic Research Service; 2022 [cited 2022 Sep 4]. Available from: https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx
   Google Scholar
• Kopf AW, Bart RS, Schrager D, et al. Curettage-Electrodesiccation treatment of basal cell carcinomas. Arch Dermatol. 1977;113(4):439–443.
   PubMedGoogle Scholar
• Paoli J, Gyllencreutz JD, Fougelberg J, et al. Nonsurgical options for the treatment of basal cell carcinoma. Dermatol Pract Concept. 2019;9(2):75–81.
   PubMedGoogle Scholar
• Smith ES, Feldman SR, Fleischer AB, et al. Characteristics of office-based visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions. Dermatol Surg. 1998;24(9):981–985.
   PubMed Web of Science ®Google Scholar
• Fleischer AB, Feldman SR, White RE, et al. Procedures for skin diseases performed by physicians in 1993 and 1994: analysis of data from the national ambulatory medical care survey. J Am Acad Dermatol. 1997;37(5 Pt 1):719–724.
   PubMed Web of Science ®Google Scholar